Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$121.16
+0.4%
$113.79
$96.43
$153.84
$34.48B1.231.84 million shs944,958 shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$251.56
+0.4%
$235.85
$211.43
$387.99
$6.85B0.95394,398 shs109,086 shs
Illumina, Inc. stock logo
ILMN
Illumina
$100.44
+0.1%
$85.04
$68.70
$156.66
$15.96B1.362.14 million shs1.42 million shs
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$1,209.08
+0.3%
$1,150.84
$946.69
$1,546.93
$25.13B1.37150,220 shs41,859 shs
10x Genomics stock logo
TXG
10x Genomics
$13.01
$9.82
$6.78
$24.76
$1.60B2.032.72 million shs2.00 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.00%+1.64%+5.25%+17.66%-3.94%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.00%+3.10%+13.19%+11.70%-6.85%
Illumina, Inc. stock logo
ILMN
Illumina
0.00%+5.96%+20.78%+35.44%-4.60%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
0.00%+2.08%+3.08%+18.31%-10.68%
10x Genomics stock logo
TXG
10x Genomics
0.00%+10.91%+39.29%+74.16%-30.61%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.7388 of 5 stars
3.34.02.53.63.40.81.3
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.8738 of 5 stars
3.45.00.04.23.22.51.9
Illumina, Inc. stock logo
ILMN
Illumina
4.8744 of 5 stars
4.23.00.04.23.13.31.3
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
4.2876 of 5 stars
2.25.00.03.33.12.51.3
10x Genomics stock logo
TXG
10x Genomics
4.6263 of 5 stars
3.24.00.04.83.32.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.54
Moderate Buy$140.9216.32% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.75
Moderate Buy$324.2528.90% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.47
Hold$127.3926.83% Upside
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
2.42
Hold$1,300.367.55% Upside
10x Genomics stock logo
TXG
10x Genomics
2.43
Hold$14.9615.00% Upside

Current Analyst Ratings Breakdown

Latest A, MTD, ILMN, TXG, and BIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
10x Genomics stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
6/26/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$1,200.00 ➝ $1,260.00
6/26/2025
10x Genomics stock logo
TXG
10x Genomics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$12.00 ➝ $13.00
6/24/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $125.00
6/24/2025
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderweight ➝ Underweight$77.00 ➝ $85.00
6/24/2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$1,325.00
6/24/2025
10x Genomics stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$12.00 ➝ $13.00
6/11/2025
Illumina, Inc. stock logo
ILMN
Illumina
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$87.00 ➝ $99.00
6/11/2025
10x Genomics stock logo
TXG
10x Genomics
Weiss Ratings
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell (E+) ➝ Sell (E+)
6/9/2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$260.00 ➝ $245.00
5/30/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$135.00
(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.51B5.29$6.24 per share19.42$21.60 per share5.61
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.57B2.67$10.39 per share24.21$234.52 per share1.07
Illumina, Inc. stock logo
ILMN
Illumina
$4.37B3.64$4.67 per share21.49$14.96 per share6.71
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$3.87B6.49$47.79 per share25.30($6.07) per share-199.19
10x Genomics stock logo
TXG
10x Genomics
$610.78M2.62N/AN/A$5.81 per share2.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.29B$4.0529.9119.933.6817.59%25.92%13.24%8/20/2025 (Estimated)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$1.84B-$76.20N/A20.21N/A-85.16%4.32%3.03%7/30/2025 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.22B-$6.07N/A19.471.98-22.25%25.54%8.62%8/5/2025 (Estimated)
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$863.14M$40.1030.1525.433.7222.17%-556.22%26.27%7/30/2025 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$182.63M-$1.30N/AN/AN/A-25.14%-23.22%-18.02%8/6/2025 (Estimated)

Latest A, MTD, ILMN, TXG, and BIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/28/2025Q2 2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.26$1.31+$0.05$0.75$1.63 billion$1.67 billion
5/8/2025Q1 2025
Illumina, Inc. stock logo
ILMN
Illumina
$0.96$0.97+$0.01$0.82$1.03 billion$1.04 billion
5/8/2025Q1 2025
10x Genomics stock logo
TXG
10x Genomics
-$0.45-$0.36+$0.09-$0.28$131.91 million$154.88 million
5/1/2025Q1 2025
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$1.73$2.54+$0.81$2.29$573.01 million$585.40 million
5/1/2025Q1 2025
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
$7.90$8.19+$0.29$7.81$876.61 million$883.74 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.990.82%N/A24.44%9 Years
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest A, MTD, ILMN, TXG, and BIO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2025
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.24800.9%7/1/20257/1/20257/23/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.55
2.09
1.60
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.18
5.99
4.43
Illumina, Inc. stock logo
ILMN
Illumina
0.63
1.86
1.48
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
N/A
1.01
0.70
10x Genomics stock logo
TXG
10x Genomics
N/A
5.37
4.68

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
95.07%
10x Genomics stock logo
TXG
10x Genomics
84.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
17,900284.07 millionN/AOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
7,70027.21 million22.57 millionOptionable
Illumina, Inc. stock logo
ILMN
Illumina
9,030158.30 million154.18 millionOptionable
Mettler-Toledo International, Inc. stock logo
MTD
Mettler-Toledo International
17,30020.78 million20.38 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240123.13 million111.57 millionOptionable

Recent News About These Companies

10x Genomics (NASDAQ:TXG) Downgraded by Wall Street Zen to Hold
10x Genomics: Stuck In Neutral
10x Genomics Settles Patent Dispute With Bruker

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$121.16 +0.50 (+0.41%)
Closing price 07/3/2025 03:46 PM Eastern
Extended Trading
$121.16 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Bio-Rad Laboratories stock logo

Bio-Rad Laboratories NYSE:BIO

$251.56 +0.91 (+0.36%)
As of 07/3/2025 03:30 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Illumina stock logo

Illumina NASDAQ:ILMN

$100.44 +0.10 (+0.10%)
Closing price 07/3/2025 03:46 PM Eastern
Extended Trading
$100.89 +0.45 (+0.45%)
As of 07/3/2025 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Mettler-Toledo International stock logo

Mettler-Toledo International NYSE:MTD

$1,209.08 +3.43 (+0.28%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$1,208.73 -0.35 (-0.03%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$13.01 0.00 (0.00%)
Closing price 07/3/2025 03:57 PM Eastern
Extended Trading
$13.04 +0.03 (+0.23%)
As of 07/3/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.